Clarius Group, LLC Merck & Co., Inc. Transaction History

Clarius Group, LLC

$1.4 Billion
Q3 2024

A detailed history of Clarius Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 23,861 shares of MRK stock, worth $2.34 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

23,861

Previous 24,946 4.35%

Holding current value

$2.34 Million

Previous $3.09 Million 12.27%

% of portfolio

0.19%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$111.15 - $128.97 $120,597 - $139,932	-1,085 Reduced 4.35%	23,861 $2.71 Million
Q2 2024 Jul 11, 2024	SELL	$123.8 - $132.96 $102,382 - $109,957	-827 Reduced 3.21%	24,946 $3.09 Million
Q1 2024 Apr 17, 2024	SELL	$113.24 - $131.95 $395,094 - $460,373	-3,489 Reduced 11.92%	25,773 $3.4 Million
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $762,169 - $829,424	7,608 Added 35.13%	29,262 $3.19 Million
Q3 2023 Oct 19, 2023	SELL	$102.95 - $114.33 $633,554 - $703,586	-6,154 Reduced 22.13%	21,654 $2.23 Million
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $198,973 - $216,872	1,832 Added 7.05%	27,808 $3.21 Million
Q1 2023 Apr 17, 2023	SELL	$102.94 - $114.86 $8,338 - $9,303	-81 Reduced 0.31%	25,976 $2.76 Million
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $35,500 - $45,516	406 Added 1.58%	26,057 $2.89 Million
Q3 2022 Oct 24, 2022	BUY	$84.53 - $94.96 $165,340 - $185,741	1,956 Added 8.25%	25,651 $2.21 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $226,007 - $256,190	2,707 Added 12.9%	23,695 $2.16 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $55,511 - $69,534	768 Added 3.8%	20,988 $1.61 Million
Q3 2021 Oct 18, 2021	SELL	$71.68 - $78.83 $11,182 - $12,297	-156 Reduced 0.77%	20,220 $1.52 Million
Q2 2021 Aug 06, 2021	SELL	$70.31 - $77.77 $8,999 - $9,954	-128 Reduced 0.62%	20,376 $1.59 Million
Q1 2021 Apr 27, 2021	SELL	$68.86 - $81.11 $181,308 - $213,562	-2,633 Reduced 11.38%	20,504 $1.58 Million
Q4 2020 Jan 15, 2021	BUY	$71.77 - $79.65 $95,454 - $105,934	1,330 Added 6.1%	23,137 $1.89 Million
Q3 2020 Oct 09, 2020	SELL	$73.18 - $82.95 $117,380 - $133,051	-1,604 Reduced 6.85%	21,807 $1.81 Million
Q2 2020 Jul 08, 2020	BUY	$70.42 - $80.13 $183,303 - $208,578	2,603 Added 12.51%	23,411 $1.81 Million
Q1 2020 Apr 24, 2020	BUY	$63.36 - $87.82 $19,768 - $27,399	312 Added 1.52%	20,808 $1.6 Million
Q4 2019 Jan 22, 2020	SELL	$77.58 - $87.54 $158,495 - $178,844	-2,043 Reduced 9.06%	20,496 $1.88 Million
Q3 2019 Oct 23, 2019	BUY	$76.08 - $82.93 $348,902 - $380,316	4,586 Added 25.54%	22,539 $1.9 Million
Q2 2019 Aug 02, 2019	BUY	$69.84 - $81.59 $155,184 - $181,292	2,222 Added 14.12%	17,953 $1.51 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $579,323 - $660,751	8,326 Added 112.44%	15,731 $1.31 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $105,949 - $122,953	1,624 Added 28.09%	7,405 $566,000
Q3 2018 Nov 13, 2018	BUY	$57.69 - $67.84 $333,505 - $392,183	5,781 New	5,781 $410,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Merck & Co., Inc. Transaction History